Literature DB >> 15847726

Non-AIDS-Defining Cancers and HIV Infection.

Soon Thye Lim1, Alexandra M Levine.   

Abstract

With fewer patients now succumbing to infectious complications of AIDS, other HIV-related morbidities such as malignancies have become increasingly important. Apart from Kaposi's sarcoma, non-Hodgkin's lymphoma, and cervical cancer, which are considered as AIDS-defining, several additional cancers, referred to as non-AIDS-defining cancers, are also statistically increased in HIV-infected persons. These include Hodgkin's disease, anal carcinoma, lung cancer, nonmelanomatous skin cancer, and testicular germ cell tumors, among others. However, the types of cancer observed at an increased frequency and the relative risks reported vary widely among studies. Although immunosuppression is consistently associated with an increased risk of AIDS-related malignancies, the role of immunosuppression in the pathogenesis of non-AIDS- defining cancers is controversial. Although data regarding the optimal management of these cancers are lacking, current studies suggest that patients with HIV-associated malignancies should be treated with similar approaches to those of their counterparts in the general population.

Entities:  

Year:  2005        PMID: 15847726     DOI: 10.1007/s11908-005-0039-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  62 in total

1.  The stressors and stress of being HIV-positive.

Authors:  S C Thompson; C Nanni; A Levine
Journal:  AIDS Care       Date:  1996-02

2.  Immune deficiency and risk for malignancy among persons with AIDS.

Authors:  Sam M Mbulaiteye; Robert J Biggar; James J Goedert; Eric A Engels
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-15       Impact factor: 3.731

3.  AIDS related neoplasms in Genoa, Italy.

Authors:  G Gabutti; M Vercelli; M G De Rosa; M A Orengo; C Casella; E Garrone; C Orlandini; N Piersantelli; A Torresin; F Rizzo
Journal:  Eur J Epidemiol       Date:  1995-12       Impact factor: 8.082

Review 4.  Hodgkin's disease and AIDS. Twenty-three new cases and a review of the literature.

Authors:  E D Ames; M S Conjalka; A F Goldberg; R Hirschman; S Jain; A Distenfeld; C E Metroka
Journal:  Hematol Oncol Clin North Am       Date:  1991-04       Impact factor: 3.722

5.  Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149).

Authors:  A M Levine; P Li; T Cheung; A Tulpule; J Von Roenn; B N Nathwani; L Ratner
Journal:  J Acquir Immune Defic Syndr       Date:  2000-08-15       Impact factor: 3.731

6.  Bronchogenic carcinoma after solid organ transplantation.

Authors:  Marc de Perrot; Dennis A Wigle; Andrew F Pierre; Ming S Tsao; Thomas K Waddell; Thomas R J Todd; Shaf H Keshavjee
Journal:  Ann Thorac Surg       Date:  2003-02       Impact factor: 4.330

7.  Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.

Authors:  O A Olivero; L M Anderson; B A Diwan; D C Haines; S W Harbaugh; T J Moskal; A B Jones; J M Rice; C W Riggs; D Logsdon; S H Yuspa; M C Poirier
Journal:  J Natl Cancer Inst       Date:  1997-11-05       Impact factor: 13.506

8.  HIV-related lung cancer in the era of highly active antiretroviral therapy.

Authors:  Mark Bower; Tom Powles; Mark Nelson; Pallav Shah; Sarah Cox; Sundhiya Mandelia; Brian Gazzard
Journal:  AIDS       Date:  2003-02-14       Impact factor: 4.177

9.  Spectrum of AIDS-associated malignant disorders.

Authors:  J J Goedert; T R Coté; P Virgo; S M Scoppa; D W Kingma; M H Gail; E S Jaffe; R J Biggar
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

10.  High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.

Authors:  Christophe Piketty; Teresa M Darragh; Isabelle Heard; Maria Da Costa; Patrick Bruneval; Michel D Kazatchkine; Joel M Palefsky
Journal:  Sex Transm Dis       Date:  2004-02       Impact factor: 2.830

View more
  3 in total

1.  Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy.

Authors:  Mads Hald Andersen
Journal:  J Natl Cancer Inst       Date:  2015-06-10       Impact factor: 13.506

2.  Chronic arsenic exposure impairs macrophage functions in the exposed individuals.

Authors:  Nilanjana Banerjee; Saptarshi Banerjee; Rupashree Sen; Apurba Bandyopadhyay; Nilendu Sarma; Papiya Majumder; Jayanta K Das; Mitali Chatterjee; Syed N Kabir; Ashok K Giri
Journal:  J Clin Immunol       Date:  2009-06-10       Impact factor: 8.317

Review 3.  Anti-regulatory T cells.

Authors:  Mads Hald Andersen
Journal:  Semin Immunopathol       Date:  2016-09-27       Impact factor: 9.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.